The Meaning Of Prophylactic - Types Of Prophylaxis In Medicine
Primary Prophylaxis: Preventing or increasing resistance to disease that has not occurred. The patient decided to have a prophylactic mastectomy because her grandmother, mother and aunts had all died of breast cancer. Related Articles. What You Should Know: ... Read Article
Chapter 3 The Role Of MicroRNA In Lung Cancer Drug Resistance ...
2 Drug Resistance in Lung Cancer Chemotherapy is amajor treatment modality in both primary and palliative care for lung cancer patients. However, some patients do not respond to such therapy, or ... Get Document
Nanoparticle-assisted Combination therapies For Effective ...
To reduce cancer drug resistance for better therapeutic effectiveness, combination chemotherapy has long been adopted in clinics Polymeric nanoparticles and polymer–drug conjugates for combination cancer therapy. Formulation Drugs Indication Status Ref. ... Content Retrieval
Rational Drug Redesign To Overcome Drug Resistance In Cancer ...
Rational Drug Redesign to Overcome Drug Resistance in Cancer Therapy: Imatinib Moving Target Ariel Ferna´ndez,1,2,3 Angela Sanguino,3 Zhenghong Peng,4 Alejandro Crespo,1 Eylem Ozturk,3,5 ... Access Content
ANG1005 - Wikipedia, The Free Encyclopedia
Potential use. This drug was specifically designed to treat brain tumors. Because of the blood brain barrier (BBB), many cancer therapy drugs are prevented from passing through the brain capillaries into the parenchyma. [6] ... Read Article
MINI-REVIEW Cancer Multidrug Resistance (MDR): A Major ...
Asian Pacific Journal of Cancer Prevention, Vol 9, 2008 1 Cancer Multidrug Resistance: A Major Impediment to Effective Chemotherapy Asian Pacific J Cancer Prev, 9 , 1-6 ... Retrieve Content
Katherine Borden - New Therapeutic Strategies And New Modes ...
Katherine Borden - New therapeutic strategies and new modes of drug resistance COPING WITH DRUG RESISTANCE IN CANCER THERAPY - Duration: 40:35. Lynn Marquis 281 views. Overcoming Drug Resistance to Cancer Therapies - Duration: 44:53. ... View Video
Towards A Targeted Multi-drug Delivery Approach To Improve ...
First-line therapy. Resistance of cancer to chemotherapy may be caused by either host factors, such as poor tolerance to Towards a targeted multi-drug delivery approach to improve therapeutic efficacy in breast cancer 1172 Expert Opin. Drug Deliv. (2010) 7(10) Expert Opin. ... Access Content
Circumventing Tumor Resistance To Chemotherapy By Nanotechnology
Circumventing Tumor Resistance to Chemotherapy by Nanotechnology 471 with a hydrophobic inner part that contains the drug. They have a kinetic behavior similar to that of liposomes. ... Get Document
ZEB1: At The Crossroads Of Epithelial-mesenchymal Transition ...
ZEB1: At the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance Peijing Zhang1, Yutong Sun2,*, and Li Ma1,3,* 1Department of Experimental Radiation Oncology; 2Department of Molecular and Cellular Oncology; The University of Texas MD Anderson Cancer Center; ... View Doc
Current Status Of Methods To Assess Cancer Drug Resistance
Current Status of Methods to Assess Cancer Drug Resistance ment of therapy, only intrinsic resistance can be veri-fied. In order to detect predictive biomarkers highly sophisticated data analytical methods have now been developed. ... Retrieve Doc
Cisplatin As An Anti-Tumor Drug: Cellular Mechanisms Of ...
Cancers 2011, 3 1352 Keywords: cisplatin; cancer; intracellular mechanisms; ROS intracellular calcium; multi drug resistance; ROS; combinatorial therapy; toxicity; cell death; DNA damage and repair; ... Fetch Doc
Drug Resistance In Cancer Therapy - GBV
Drug Resistance in Cancer Therapy edited by: ROBERT F. OZOLS, M.D., Ph.D. Fox Chase Cancer Center 7701 Burholme Auenue Philadelphia, PA 19111, USA w ... Retrieve Doc
Drug Resistance And Its Solution In Chemotherapy Of ...
Drug Resistance and its Solution in Chemotherapy for ovarian cancer with drug resistance, usually adopt 21d source as anthracycline, vinblastine, chemotherapy can avoid drug resistance from single drug therapy. Therefore, ... Read Document
Failure Of Pancreatic Cancer Chemotherapy: Consequences Of ...
Failure of Pancreatic Cancer Chemotherapy: Consequences of Drug Resistance Mechanisms 145 Gemcitabine mainly acts by three mechanisms as shown in figure 1. ... Read More
What We Know About Ovarian Cancers Has Surprising Gaps
March 2, 2016 - Ovarian cancer should not be categorized as a single disease, but rather as a constellation of different cancers involving the ovary, yet questions remain on how and where various ovarian cancers arise, says a new congressionally mandated report from the National Academies of Sciences, Engineering, and Medicine. ... Read News
PDF - Breast Cancer Research
Trastuzumab-based therapy. Additionally, drug discovery programs are focusing on tion of an anti-p185her2 antibody for human cancer therapy. Proc Natl Acad Sci USA 1992, 89 down-regulation is associated with trastuzumab resistance in breast cancer cells. Cancer Res 2004, 64:3981-3986 ... Access Content
Cancer Cell - Wikipedia, The Free Encyclopedia
The enzyme telomerase is used to extend the cancer cell's life span. While the telomeres of most cells shortens after each division eventually causing the cell to die, telomerase extends the cell's telomeres. Cancer stem cells and drug resistance ... Read Article
CHAPTER 3 Principles Of Chemotherapy - Thymic
CHAPTER 3 Principles of chemotherapy Ray Page, DO, The effective use of cancer chemotherapy requires an understanding of the principles of tumor biology, cellular kinetics, pharmacology, and drug resis- drug resistance, and decreasing chemotherapy toxicities. ... Read Document
Nanoparticle-based Combination therapy Toward Overcoming drug ...
Review Nanoparticle-based combination therapy toward overcoming drug resistance in cancer Che-Ming Jack Hu, Liangfang Zhang* Department of Nanoengineering and Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093, USA ... Retrieve Content
Evolution Of resistance To Anti-cancer therapy During General ...
Evolution of resistance to anti-cancer therapy during general dosing schedules Jasmine Foo and Franziska Michor* Memorial Sloan-Kettering Cancer Center ... Access Document
Basilea Launching Antifungal CRESEMBA(R) (isavuconazole) In Germany
BASEL, Switzerland -- Basilea Pharmaceutica Ltd. (SIX: BSLN) hosts a symposium to support the launch of the new azole antifungal CRESEMBA(R) (isavuconazole) in Germany. The symposium will be held on March ... Read News
No comments:
Post a Comment